WHO ICTRP trial
A clinical trial to study the effects of two drugs Peg G-CSF and Grafeel® in the…
CTRI/2009/091/000694 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2009/091/000694 |
|---|---|
| Public title | A clinical trial to study the effects of two drugs Peg G-CSF and Grafeel® in the prevention of reduction in neutrophil counts in cancer patients caused by drugs used to treat cancer. |
| Scientific title | A randomized, multi-center, open label study to evaluate the efficacy and safety of Peg G-CSF as compared to Grafeel® in the prophylaxis of severe neutropenia in cancer patients receiving cytotoxic chemotherapy. |
| Primary sponsor | DR.REDDY'S LABORATORIES LTD.Biologics Development Centre , Survey No.47, Bachupalli, Qutubullapur, Hyderabad-500090, A.P, India Fax: +91-40-44644507, 91-40-23041418 |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Interventions | Intervention1: PEG-GCSF: 6 mg single dose administered via SC route Control Intervention1: Grafeel®: 5µg/kg/day administered via SC route. |
| Registration date | Sep 25, 2009 |
| Target size | 150 |
| Secondary IDs | CDP/03/07 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: